According to Pacific Biosciences
's latest financial reports the company has $0.63 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $0.63 B | -18.24% |
2022-12-31 | $0.77 B | -26.05% |
2021-12-31 | $1.04 B | 227.59% |
2020-12-31 | $0.31 B | 549.33% |
2019-12-31 | $49.09 M | -52.03% |
2018-12-31 | $0.10 B | 62.8% |
2017-12-31 | $62.87 M | -12.65% |
2016-12-31 | $71.97 M | -12.51% |
2015-12-31 | $82.27 M | -18.82% |
2014-12-31 | $0.10 B | -9.94% |
2013-12-31 | $0.11 B | 11.88% |
2012-12-31 | $0.10 B | -43.31% |
2011-12-31 | $0.17 B | -37.45% |
2010-12-31 | $0.28 B | 205.9% |
2009-12-31 | $92.73 M | -12.56% |
2008-12-31 | $0.10 B |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
Thermo Fisher Scientific TMO | $8.07 B | 1,179.19% | ๐บ๐ธ USA |
General Electric GE | $22.67 B | 3,490.82% | ๐บ๐ธ USA |
Illumina ILMN | $1.05 B | 66.93% | ๐บ๐ธ USA |
PerkinElmer
PKI | $2.46 B | 289.78% | ๐บ๐ธ USA |
Luminex LMNX | N/A | N/A | ๐บ๐ธ USA |
NanoString Technologies NSTG | $97.1 M | -84.62% | ๐บ๐ธ USA |